Table 2. In-vitro antibacterial activities of inhibitors of PBPs from resistant species.

Bacterial Strain	MIC (µg/mL)
	1	2	6	9	10	12	Ampicillin
Escherichia coli ATCC 8739	>1024	>512	>512	>512	>512	>512	4
Proteus mirabilis ATCC 29936	>1024	>512	>512	>512	>512	>512	2
Citrobacter freundii ATCC 8090	>1024	>512	>512	>512	>512	>512	128
Pseudomonas aeruginosa ATCC 27853	>1024	>512	>512	>512	>512	>512	>1024
Klebsiella pneumoniae ATCC 13883	>1024	>512	>512	>512	>512	>512	256
Micrococcus luteus ATCC 9341	2	>512	32	16	256	256	0.5
Listeria innocua ATCC 33090	16	>512	64	16	256	>512	0.25
Listeria monocytogenes ATCC 14780	16	>512	64	16	32	>512	0.5
Bacillus subtilis ATCC 6633	2	>512	128	32	256	>512	0.5
Enterococcus faecalis ATCC 7937	16	>512	64	64	256	>512	2
Enterococcus faecalis ATCC 29212	32	>512	32	64	256	256	2
Enterococcus faecium ATCC 19434	64	>512	256	16	128	>512	64
Enterococcus hirae ATCC 8790	16	>512	32	16	128	256	64
Streptococcus pneumoniae ATCC 49619	1	>512	32	1	2	256	0.06
Streptococcus pneumoniae ATCC 33400	1	>512	64	1	2	256	0.03
Streptococcus pneumoniae D39	1	>512	16	1	2	256	0.06
Staphylococcus epidermidis ATCC 12228	32	>512	16	8	128	256	16
Staphylococcus aureus ATCC 25923	32	>512	16	32	128	512	0.25
Staphylococcus aureus ATCC 43300 (MRSA)	32	>512	128	32	256	512	1024
Staphylococcus aureus mp 1 (inducible MRSA)	32	>512	128	32	256	512	1024